Search Results - Philip O. Buck

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Time and cost of administering COVID-19 mRNA vaccines in the United States by Benjamin Yarnoff, Steven Bodhaine, Ed Cohen, Philip O. Buck

    Published in Human Vaccines & Immunotherapeutics (2021-11-01)
    Get full text
    Article


  2. 2

    Is patient insurance type related to physician recommendation, administration and referral for adult vaccination? A survey of US physicians by Michelle McNamara, Philip O. Buck, Songkai Yan, Leonard R. Friedland, Kristin Lerch, Alysa Murphy, Cosmina Hogea

    Published in Human Vaccines & Immunotherapeutics (2019-09-01)
    Get full text
    Article


  3. 3

    Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019 by Brandon J. Patterson, Chi-Chang Chen, Catherine B. McGuiness, Lisa I. Glasser, Kainan Sun, Philip O. Buck

    Published in Human Vaccines & Immunotherapeutics (2021-08-01)
    Get full text
    Article


  4. 4

    The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program by Tinevimbo Shiri, Marc Evans, Carla A. Talarico, Angharad R. Morgan, Maaz Mussad, Philip O. Buck, Phil McEwan, William David Strain

    Published in Vaccines (2022-01-01)
    Get full text
    Article


  5. 5

    Vaccinating Adolescents and Children Significantly Reduces COVID-19 Morbidity and Mortality across All Ages: A Population-Based Modeling Study Using the UK as an Example by Tinevimbo Shiri, Marc Evans, Carla A. Talarico, Angharad R. Morgan, Maaz Mussad, Philip O. Buck, Phil McEwan, William David Strain

    Published in Vaccines (2021-10-01)
    Get full text
    Article


  6. 6

    New Vaccine Platforms—Novel Dimensions of Economic and Societal Value and Their Measurement by Philip O. Buck, Dumingu Aparna Gomes, Ekkehard Beck, Noam Kirson, Matthew Mattera, Stuart Carroll, Bernhard Ultsch, Kavisha Jayasundara, Mathieu Uhart, Louis P. Garrison, Jr.

    Published in Vaccines (2024-02-01)
    Get full text
    Article


  7. 7

    Retrospective study of the use of an influenza disease two-tiered classification system to characterize clinical severity in US children by Amber Hsiao, Philip O. Buck, Arnold Yee, John Hansen, Edwin M. Lewis, Laurie L. Aukes, Emad Yanni, Rafik Bekkat-Berkani, Anne Schuind, Nicola P. Klein

    Published in Human Vaccines & Immunotherapeutics (2020-08-01)
    Get full text
    Article


  8. 8

    Estimated Public Health Impact of the Recombinant Zoster Vaccine by Brandon J. Patterson, PharmD, PhD, Philip O. Buck, PhD, MPH, Desmond Curran, PhD, Desirée Van Oorschot, MSc, Justin Carrico, BS, William L. Herring, PhD, Yuanhui Zhang, PhD, Jeffrey J. Stoddard, MD

    Get full text
    Article


Search Tools: